2.28

5.56% 0.12

Pre-market: 2.35 0.07 +3.07%

Accendra Health Inc (ACH)

Overview News Price History Discussions Forecast Dividend History

Accendra Health Inc stock is traded at $2.28, with a volume of 1.12M. It is up +5.56% in the last 24 hours and down -5.79% over the past month. Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.

Previous Close:

$2.16

Open:

$2.24

24h Volume:

1.12M

Relative Volume:

1.42

Market Cap:

$174.28M

Revenue:

$4.72B

Net Income/Loss:

$-123.85M

P/E Ratio:

-0.1595

EPS:

-14.2981

Net Cash Flow:

$-303.12M

1W Performance:

+13.43%

1M Performance:

-5.79%

6M Performance:

-82.02%

1Y Performance:

-82.02%

1-Day Range:

$2.18

$2.38

1-Week Range:

$2.04

$2.38

52-Week Range:

$1.885

$2.71

Accendra Health Inc Stock (ACH) Company Profile

Name

Accendra Health Inc

Sector

Healthcare (1114)

Industry

Medical Distribution (11)

Phone

(804) 277-4304

Address

10900 NUCKOLS ROAD, GLEN ALLEN

Employee

6,500

Twitter

Next Earnings Date

Latest SEC Filings

ACH's Discussions on Twitter

Compare ACH vs MCK, COR, CAH, HSIC, AHG

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACH Accendra Health Inc	2.28	174.28M	4.72B	-123.85M	-303.12M	-14.30
MCK Mckesson Corporation	865.36	106.00B	397.96B	4.55B	9.64B	34.77
COR Cencora Inc	314.14	61.11B	325.78B	1.64B	3.61B	8.3139
CAH Cardinal Health Inc	211.31	49.72B	244.67B	1.68B	5.51B	6.9487
HSIC Henry Schein Inc	73.70	8.45B	13.18B	419.00M	521.00M	3.2704
AHG Akso Health Group Adr	2.28	1.95B	14.85M	-136.07M	7.23M	-0.4726

Accendra Health Inc Stock (ACH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-03-25	Downgrade	UBS	Buy → Neutral
Jul-19-24	Upgrade	Citigroup	Neutral → Buy
Feb-26-24	Initiated	Leerink Partners	Market Perform
Jan-03-24	Initiated	Barclays	Equal Weight
Oct-13-22	Downgrade	Citigroup	Buy → Neutral
Oct-12-22	Downgrade	BofA Securities	Buy → Underperform
Oct-12-22	Downgrade	Robert W. Baird	Outperform → Neutral
Apr-26-22	Resumed	Citigroup	Buy
Apr-01-22	Resumed	Credit Suisse	Neutral
Mar-30-22	Resumed	JP Morgan	Underweight
Mar-23-22	Upgrade	HSBC Securities	Reduce → Hold
Apr-08-21	Upgrade	JP Morgan	Neutral → Overweight
Mar-08-21	Upgrade	Goldman	Sell → Buy
Dec-17-20	Upgrade	UBS	Neutral → Buy
Sep-25-20	Upgrade	Barclays	Underweight → Equal Weight
Jul-21-20	Upgrade	BofA Securities	Neutral → Buy
Jul-21-20	Upgrade	Robert W. Baird	Neutral → Outperform
Jul-14-20	Upgrade	Credit Suisse	Neutral → Outperform
May-05-20	Downgrade	Robert W. Baird	Outperform → Neutral
Apr-23-20	Resumed	Credit Suisse	Neutral
Jan-21-20	Upgrade	Robert W. Baird	Neutral → Outperform
Jan-07-20	Downgrade	Goldman	Neutral → Sell
Nov-15-19	Upgrade	CLSA	Underperform → Outperform
Sep-06-19	Reiterated	BofA/Merrill	Neutral
Apr-10-19	Reiterated	BofA/Merrill	Neutral
Apr-03-19	Upgrade	BofA/Merrill	Neutral → Buy
Apr-01-19	Upgrade	JP Morgan	Underweight → Overweight
Jan-18-19	Upgrade	HSBC Securities	Hold → Buy
Jan-17-19	Initiated	UBS	Neutral
Jan-15-19	Upgrade	CLSA	Underperform → Outperform
Dec-14-18	Downgrade	Morgan Stanley	Overweight → Underweight
Dec-12-18	Downgrade	Goldman	Buy → Neutral
Sep-28-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Apr-11-18	Downgrade	CLSA	Outperform → Sell
Apr-10-18	Upgrade	Credit Suisse	Neutral → Outperform
Mar-26-18	Upgrade	Goldman	Sell → Neutral
Nov-02-17	Downgrade	HSBC Securities	Buy → Hold
Mar-24-16	Upgrade	Goldman	Sell → Neutral
Dec-07-15	Downgrade	Goldman	Neutral → Sell
Aug-31-15	Upgrade	Credit Suisse	Underperform → Neutral
Aug-01-12	Initiated	HSBC Securities	Underweight
Aug-05-09	Upgrade	Citigroup	Sell → Buy
Dec-01-08	Downgrade	HSBC Securities	Neutral → Underweight

View All

Accendra Health Inc Stock (ACH) Latest News

Mar 30, 2026

Kevin M. Webb reports 5.61% stake in Accendra Health (NASDAQ: ACH) - Stock Titan

Mar 30, 2026

Owens & Minor Appoints Colin Bain as Chief Products Officer, Effective March 30, 2026 - marketscreener.com

Mar 30, 2026

Mar 27, 2026

ACH Stock Price, News & Analysis | Accendra Health - Stock Titan

Mar 27, 2026

Mar 26, 2026

Vanguard disaggregates holdings; Accendra Health (ACH) listed as 0 shares in amendment - Stock Titan

Mar 26, 2026

Mar 24, 2026

Accendra Health (ACH) CEO surrenders shares to cover RSU tax obligations - Stock Titan

Mar 24, 2026

Accendra Health (ACH) CFO surrenders 11,286 shares for tax withholding - Stock Titan

Mar 24, 2026

Accendra Health (ACH) COO surrenders shares for tax withholding, retains stake - Stock Titan

Mar 24, 2026

Accendra Health (ACH) EVP uses 9,347 shares to cover tax withholding - Stock Titan

Mar 24, 2026

Mar 21, 2026

OMI SEC FilingsOwens & Minor 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 21, 2026

Mar 16, 2026

Tranche Update on Accendra Health, Inc.'s Equity Buyback Plan announced on February 28, 2025. - marketscreener.com

Mar 16, 2026

Fitch Maintains Accendra Health's Rating Watches; Withdraws Ratings - marketscreener.com

Mar 16, 2026

Mar 15, 2026

Accendra Health CFO granted 85,067 restricted shares | ACH Insider Trading - Stock Titan

Mar 10, 2026

Feb 28, 2026

ACH Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 28, 2026

Feb 27, 2026

Owens & Minor, Inc. (OMI) Stock Analysis: Is The 94% Potential Upside Worth The Risk? - directorstalkinterviews.com

Feb 27, 2026

Feb 26, 2026

Owens & Minor, Inc. (NYSE:OMI) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 26, 2026

Feb 25, 2026

Accendra Health, Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:ACH) 2026-02-25 - Seeking Alpha

Feb 25, 2026

Accendra Health (ACH) Price Target Decreased by 12.16% to 3.32 - Nasdaq

Feb 25, 2026

Feb 24, 2026

Accendra Health (ACH) Reports 2025 Revenue of $2.8B and Shift Toward Core Home-Based Care - Insider Monkey

Feb 24, 2026

Feb 23, 2026

UBS cuts Accendra Health stock price target on 2026 guidance By Investing.com - Investing.com Canada

Feb 23, 2026

UBS cuts Accendra Health stock price target on 2026 guidance - Investing.com South Africa

Feb 23, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bicara Therapeutics Inc. (BCAX), Accendra Health (ACH) and Travere Therapeutics (TVTX) - The Globe and Mail

Feb 23, 2026

Feb 22, 2026

MSN Money - MSN

Feb 22, 2026

Tighter CMS Coverage Rules Put Accendra Health’s Non-Invasive Ventilation Revenue and Liquidity at Risk - TipRanks

Feb 22, 2026

Feb 20, 2026

Accendra Health: Debt Reduction Creates Long-Term Opportunity (Upgrade) (NYSE:ACH) - Seeking Alpha

Feb 20, 2026

Accendra Health (ACH) Faces Lowered Price Target by Leerink Part - GuruFocus

Feb 20, 2026

Accendra Health bets on Optum contract, leaner structure - HME News

Feb 20, 2026

Accendra Health : Reports Fourth Quarter 2025 Financial Results Prepared Remarks - marketscreener.com

Feb 20, 2026

Accendra Health sees 3% YOY growth, embarks on ‘next chapter’ - HME News

Feb 20, 2026

Accendra Health earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria

Feb 20, 2026